{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:51:29Z","timestamp":1794441089633,"version":"4.9.1"},"reference-count":281,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82192915"],"award-info":[{"award-number":["82192915"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.pharmthera.2022.108314","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T02:05:45Z","timestamp":1669082745000},"page":"108314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"special_numbering":"C","title":["A natural products solution to diabetic nephropathy therapy"],"prefix":"10.1016","volume":"241","author":[{"given":"Qichao","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2022.108314_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109732","article-title":"Keap1\/Nrf2\/ARE signaling unfolds therapeutic targets for redox imbalanced-mediated diseases and diabetic nephropathy","volume":"123","author":"Adelusi","year":"2020","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108314_bb0010","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.3390\/jcm9092916","article-title":"Melatonin improves mitochondrial dynamics and function in the kidney of z\u00fccker diabetic fatty rats","volume":"9","author":"Agil","year":"2020","journal-title":"Journal of Clinical Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108314_bb0015","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jaci.2010.11.050","article-title":"Interleukins, from 1 to 37, and interferon-\u03b3: Receptors, functions, and roles in diseases","volume":"127","author":"Akdis","year":"2011","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cca.2021.09.003","article-title":"Pyroptosis in diabetic nephropathy","volume":"523","author":"Al Mamun","year":"2021","journal-title":"Clinica Chimica Acta"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108314_bb0025","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jvim.15454","article-title":"The renin-angiotensin-aldosterone system and its suppression","volume":"33","author":"Ames","year":"2018","journal-title":"Journal of Veterinary Internal Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108314_bb0030","first-page":"356","article-title":"Effects and clinical significance of pentoxifylline on the oxidative stress of rats with diabetic nephropathy","volume":"35","author":"An","year":"2015","journal-title":"Journal of Huazhong University of Science and Technology. Medical Sciences"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108314_bb0035","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.3390\/ijms19103107","article-title":"Immunomodulatory effects of the nutraceutical garlic derivative allicin in the progression of diabetic nephropathy","volume":"19","author":"Arellano Buend\u00eda","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0040","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrneph.2017.142","article-title":"Modelling diabetic nephropathy in mice","volume":"14","author":"Azushima","year":"2018","journal-title":"Nature Reviews Nephrology"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108314_bb0045","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/ptr.6463","article-title":"Eriodictyol inhibits high glucose-induced extracellular matrix accumulation, oxidative stress, and inflammation in human glomerular mesangial cells","volume":"33","author":"Bai","year":"2019","journal-title":"Phytotherapy Research"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108314_bb0050","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41574-021-00512-2","article-title":"Type 2 diabetes mellitus in older adults: clinical considerations and management","volume":"17","author":"Bellary","year":"2021","journal-title":"Nature Reviews. Endocrinology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108314_bb0055","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","article-title":"Nrf2-Keap1 signaling in oxidative and reductive stress","volume":"1865","author":"Bellezza","year":"2018","journal-title":"Biochimica et Biophysica Acta, Molecular Cell Research"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108314_bb0060","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.3390\/ijms22083948","article-title":"Molecular imaging of apoptosis: The case of caspase-3 radiotracers","volume":"22","author":"Beroske","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1479-7364-5-1-30","article-title":"Evolutionary divergence and functions of the human interleukin (IL) gene family","volume":"5","author":"Brocker","year":"2010","journal-title":"Human Genomics"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108314_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2020.151941","article-title":"Dioscin protects against diabetic nephropathy by inhibiting renal inflammation through TLR4\/NF-\u03baB pathway in mice","volume":"225","author":"Cai","year":"2020","journal-title":"Immunobiology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0075","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3389\/fphar.2020.01249","article-title":"Resveratrol modulates the gut microbiota and inflammation to protect against diabetic nephropathy in mice","volume":"11","author":"Cai","year":"2020","journal-title":"Frontiers in Pharmacology"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108314_bb0080","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s11255-019-02241-y","article-title":"The protective effect of Cordycepin on diabetic nephropathy through autophagy induction in vivo and in vitro","volume":"51","author":"Cao","year":"2019","journal-title":"International Urology and Nephrology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0085","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.2147\/DMSO.S277869","article-title":"LncRNA MIR503HG promotes high-glucose-induced proximal tubular cell apoptosis by targeting miR-503-5p\/Bcl-2 pathway","volume":"13","author":"Cao","year":"2020","journal-title":"Diabetes, Metabolic Syndrome and Obesity"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.580406","article-title":"Magnoflorine ameliorates inflammation and fibrosis in rats with diabetic nephropathy by mediating the stability of lysine-specific demethylase 3A","volume":"11","author":"Chang","year":"2020","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0095","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.8016","article-title":"Long noncoding RNA MEG3 suppresses podocyte injury in diabetic nephropathy by inactivating Wnt\/\u03b2-catenin signaling","volume":"7","author":"Che","year":"2019","journal-title":"PeerJ"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153614","article-title":"Trigonelline induces autophagy to protect mesangial cells in response to high glucose via activating the miR-5189-5p-AMPK pathway","volume":"92","author":"Chen","year":"2021","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0105","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13098-022-00798-w","article-title":"Trigonelline reverses high glucose-induced proliferation, fibrosis of mesangial cells via modulation of Wnt signaling pathway","volume":"14","author":"Chen","year":"2022","journal-title":"Diabetology & Metabolic Syndrome"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0110","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.biopha.2018.03.169","article-title":"Tangeretin inhibits high glucose-induced extracellular matrix accumulation in human glomerular mesangial cells","volume":"102","author":"Chen","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0115","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12906-018-2257-y","article-title":"Naringin ameliorates the high glucose-induced rat mesangial cell inflammatory reaction by modulating the NLRP3 Inflammasome","volume":"18","author":"Chen","year":"2018","journal-title":"BMC Complementary and Alternative Medicine"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118835","article-title":"Amygdalin alleviates renal injury by suppressing inflammation, oxidative stress and fibrosis in streptozotocin-induced diabetic rats","volume":"265","author":"Chen","year":"2021","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118120","article-title":"Study on the inhibitive effect of Catalpol on diabetic nephropathy","volume":"257","author":"Chen","year":"2020","journal-title":"Life Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0130","first-page":"119","article-title":"Quercetin suppresses NF-\u03baB and MCP-1 expression in a high glucose-induced human mesangial cell proliferation model","volume":"30","author":"Chen","year":"2012","journal-title":"International Journal of Molecular Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108314_bb0135","first-page":"709","article-title":"Astragaloside IV ameliorates high glucoseinduced renal tubular epithelialmesenchymal transition by blocking mTORC1\/p70S6K signaling in HK2 cells","volume":"43","author":"Chen","year":"2019","journal-title":"International Journal of Molecular Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108314_bb0140","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1159\/000362974","article-title":"Down-regulation of PERK-ATF4-CHOP pathway by astragaloside IV is associated with the inhibition of endoplasmic reticulum stress-induced podocyte apoptosis in diabetic rats","volume":"33","author":"Chen","year":"2014","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0145","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.biopha.2019.01.030","article-title":"Hesperetin ameliorates diabetic nephropathy in rats by activating Nrf2\/ARE\/glyoxalase 1 pathway","volume":"111","author":"Chen","year":"2019","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0150","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3389\/fphar.2019.01477","article-title":"Catalpol ameliorates podocyte injury by stabilizing cytoskeleton and enhancing autophagy in diabetic nephropathy","volume":"10","author":"Chen","year":"2019","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0155","doi-asserted-by":"crossref","DOI":"10.1186\/s12906-019-2656-8","article-title":"The protective effect and mechanism of catalpol on high glucose-induced podocyte injury","volume":"19","author":"Chen","year":"2019","journal-title":"BMC Complementary and Alternative Medicine"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108314_bb0160","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/s41401-020-0475-6","article-title":"Polydatin attenuates renal fibrosis in diabetic mice through regulating the Cx32-Nox4 signaling pathway","volume":"41","author":"Chen","year":"2020","journal-title":"Acta Pharmacologica Sinica"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0165","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/ckj\/sfz137","article-title":"Tumor necrosis factor-\u03b1 blockade ameliorates diabetic nephropathy in rats","volume":"14","author":"Cheng","year":"2021","journal-title":"Clinical Kidney Journal"},{"issue":"24","key":"10.1016\/j.pharmthera.2022.108314_bb0170","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.3390\/molecules24244474","article-title":"Amelioration of hyperglycemia-induced nephropathy by 3,3\u2032-diindolylmethane in diabetic mice","volume":"24","author":"Choi","year":"2019","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108314_bb0175","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.2010010010","article-title":"Pathologic classification of diabetic nephropathy","volume":"21","author":"Cohen","year":"2010","journal-title":"Journal of the American Society of Nephrology"},{"issue":"10225","key":"10.1016\/j.pharmthera.2022.108314_bb0180","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"Collaboration","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/2615286","article-title":"Research progress on mechanism of podocyte depletion in diabetic nephropathy","volume":"2017","author":"Dai","year":"2017","journal-title":"Journal of Diabetes Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108314_bb0190","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrc.2015.17","article-title":"Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies","volume":"16","author":"Delbridge","year":"2016","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2350-15-9","article-title":"Endothelial nitric oxide synthase gene polymorphisms and risk of diabetic nephropathy: a systematic review and meta-analysis","volume":"15","author":"Dellamea","year":"2014","journal-title":"BMC Medical Genetics"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0200","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cbi.2019.05.004","article-title":"Activation of 20-HETE\/PPARs involved in reno-therapeutic effect of naringenin on diabetic nephropathy","volume":"307","author":"Ding","year":"2019","journal-title":"Chemico-Biological Interactions"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0205","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.phymed.2018.01.026","article-title":"Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome","volume":"41","author":"Ding","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/5205903","article-title":"Protective effects of grape seed proanthocyanidins on the kidneys of diabetic rats through the Nrf2 signalling pathway","volume":"2020","author":"Ding","year":"2020","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0215","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.biopha.2018.10.192","article-title":"Effect of hesperidin treatment on \u03b1-Klotho\/FGF-23 pathway in rats with experimentally-induced diabetes","volume":"109","author":"Dokumacioglu","year":"2019","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0220","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.2147\/DDDT.S171286","article-title":"Combination of Ginsenoside Rg1 and Astragaloside IV reduces oxidative stress and inhibits TGF-\u03b21\/Smads signaling cascade on renal fibrosis in rats with diabetic nephropathy","volume":"12","author":"Du","year":"2018","journal-title":"Drug Design, Development and Terapy"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108314_bb0225","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3390\/ijms22041651","article-title":"Geniposide improves diabetic nephropathy by enhancing ULK1-mediated autophagy and reducing oxidative stress through AMPK activation","volume":"22","author":"Dusabimana","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0230","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12986-019-0419-7","article-title":"Folic acid and melatonin mitigate diabetic nephropathy in rats via inhibition of oxidative stress","volume":"17","author":"Ebaid","year":"2020","journal-title":"Nutrition and Metabolism"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0235","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/0960327114531995","article-title":"Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats","volume":"34","author":"Elbe","year":"2015","journal-title":"Human & Experimental Toxicology"},{"issue":"5\u20136","key":"10.1016\/j.pharmthera.2022.108314_bb0240","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.vph.2011.07.007","article-title":"Tyrosine kinase inhibitor, genistein, reduces renal inflammation and injury in streptozotocin-induced diabetic mice","volume":"55","author":"Elmarakby","year":"2011","journal-title":"Vascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0245","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cyto.2016.01.014","article-title":"The role of IL-18 in type 1 diabetic nephropathy: The problem and future treatment","volume":"81","author":"Elsherbiny","year":"2016","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0250","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12906-019-2728-9","article-title":"Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats","volume":"19","author":"Fan","year":"2019","journal-title":"BMC Complementary and Alternative Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108314_bb0255","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.arcmed.2020.05.008","article-title":"Melatonin ameliorates renal fibrosis through the inhibition of NF-\u03baB and TGF-\u03b21\/Smad3 pathways in db\/db diabetic mice","volume":"51","author":"Fan","year":"2020","journal-title":"Archives of Medical Research"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0260","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cytogfr.2017.03.003","article-title":"IL-6 signaling in diabetic nephropathy: From pathophysiology to therapeutic perspectives","volume":"37","author":"Feigerlov\u00e1","year":"2017","journal-title":"Cytokine & Growth Factor Reviews"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108314_bb0265","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3892\/ijmm.2021.4996","article-title":"Astragaloside IV ameliorates diabetic nephropathy in db\/db mice by inhibiting NLRP3 inflammasomemediated inflammation","volume":"48","author":"Feng","year":"2021","journal-title":"International Journal of Molecular Medicine"},{"issue":"7708","key":"10.1016\/j.pharmthera.2022.108314_bb0270","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41586-018-0162-7","article-title":"Disruption of the beclin 1\u2013BCL2 autophagy regulatory complex promotes longevity in mice","volume":"558","author":"Fern\u00e1ndez","year":"2018","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108314_bb0275","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1039\/D1RA90018H","article-title":"Retraction: Ligustrazine attenuates renal damage by inhibiting endoplasmic reticulum stress in diabetic nephropathy by inactivating MAPK pathways","volume":"11","author":"Fisher","year":"2021","journal-title":"RSC Advances"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0280","first-page":"14","article-title":"Role of inflammation in diabetic nephropathy","volume":"4","author":"Fornoni","year":"2008","journal-title":"Current Diabetes Reviews"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2022.108314_bb0285","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11010-020-03758-y","article-title":"Rutin ameliorates metabolic acidosis and fibrosis in alloxan induced diabetic nephropathy and cardiomyopathy in experimental rats","volume":"471","author":"Ganesan","year":"2020","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108314_bb0290","doi-asserted-by":"crossref","first-page":"12275","DOI":"10.1080\/21655979.2022.2067293","article-title":"Triptolide inhibits oxidative stress and inflammation via the microRNA-155-5p\/brain-derived neurotrophic factor to reduce podocyte injury in mice with diabetic nephropathy","volume":"13","author":"Gao","year":"2022","journal-title":"Bioengineered"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108314_bb0295","first-page":"1447","article-title":"Grape seed proanthocyanidins protect against streptozotocininduced diabetic nephropathy by attenuating endoplasmic reticulum stressinduced apoptosis","volume":"18","author":"Gao","year":"2018","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0300","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cbi.2018.01.010","article-title":"Gallic acid attenuates type I diabetic nephropathy in rats","volume":"282","author":"Garud","year":"2018","journal-title":"Chemico-Biological Interactions"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108314_bb0305","first-page":"790","article-title":"The effect of pentoxifylline on reduction of proteinuria among patients with type 2 diabetes under blockade of angiotensin system: a double blind and randomized clinical trial","volume":"32","author":"Ghorbani","year":"2012","journal-title":"Nefrologia\u202f: publicacion oficial de la Sociedad Espanola Nefrologia"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108314_bb0310","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.intimp.2012.10.004","article-title":"Trigonelline ameliorates diabetic hypertensive nephropathy by suppression of oxidative stress in kidney and reduction in renal cell apoptosis and fibrosis in streptozotocin induced neonatal diabetic (nSTZ) rats","volume":"14","author":"Ghule","year":"2012","journal-title":"International Immunopharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0315","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.2697","article-title":"Autophagy: cellular and molecular mechanisms","volume":"221","author":"Glick","year":"2010","journal-title":"The Journal of Pathology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0320","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1476-511X-13-184","article-title":"Renoprotective, anti-oxidative and anti-apoptotic effects of oral low-dose quercetin in the C57BL\/6J model of diabetic nephropathy","volume":"13","author":"Gomes","year":"2014","journal-title":"Lipids in Health and Disease"},{"issue":"19","key":"10.1016\/j.pharmthera.2022.108314_bb0325","doi-asserted-by":"crossref","first-page":"9054","DOI":"10.1039\/D1FO01182K","article-title":"A novel polysaccharide obtained from siraitia grosvenorii alleviates inflammatory responses in a diabetic nephropathy mouse model via the TLR4-NF-\u03baB pathway","volume":"12","author":"Gong","year":"2021","journal-title":"Food & Function"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0330","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2013.03.014","article-title":"Nox4 and diabetic nephropathy: With a friend like this, who needs enemies?","volume":"61","author":"Gorin","year":"2013","journal-title":"Free Radical Biology and Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108314_bb0335","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.cyto.2013.01.008","article-title":"Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-\u03baB-mediated inflammatory genes expression","volume":"61","author":"Gui","year":"2013","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0340","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3892\/etm.2017.4509","article-title":"Rutin suppresses high glucose-induced ACTA2 and p38 protein expression in diabetic nephropathy","volume":"14","author":"Han","year":"2017","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108314_bb0345","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1002\/jcp.26092","article-title":"Triptolide prevents extracellular matrix accumulation in experimental diabetic kidney disease by targeting microRNA-137\/Notch1 pathway","volume":"233","author":"Han","year":"2018","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0350","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.2147\/DDDT.S257613","article-title":"Hirudin protects against kidney damage in streptozotocin-induced diabetic nephropathy rats by inhibiting inflammation via P38 MAPK\/NF-\u03baB pathway","volume":"14","author":"Han","year":"2020","journal-title":"Drug Design, Development and Therapy"},{"issue":"19\u201320","key":"10.1016\/j.pharmthera.2022.108314_bb0355","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.lfs.2012.09.003","article-title":"Preventive effects of rutin on the development of experimental diabetic nephropathy in rats","volume":"91","author":"Hao","year":"2012","journal-title":"Life Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0360","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41392-020-0142-x","article-title":"A novel role of LRP5 in tubulointerstitial fibrosis through activating TGF-beta\/Smad signaling","volume":"5","author":"He","year":"2020","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108314_bb0365","doi-asserted-by":"crossref","first-page":"F614","DOI":"10.1152\/ajprenal.90500.2008","article-title":"C-peptide reverses TGF-\u03b21-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy","volume":"296","author":"Hills","year":"2009","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0370","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbrc.2020.12.014","article-title":"Podocyte RNF166 deficiency alleviates diabetic nephropathy by mitigating mitochondria impairment and apoptosis via regulation of CYLD signal","volume":"545","author":"Hongbo","year":"2021","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108314_bb0375","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1159\/000486154","article-title":"Salvianolic acid A protects against diabetic nephropathy through ameliorating glomerular endothelial dysfunction via inhibiting AGE-RAGE signaling","volume":"44","author":"Hou","year":"2018","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/2865912","article-title":"Glycyrrhizic acid prevents diabetic nephropathy by activating AMPK\/SIRT1\/PGC-1\u03b1 signaling in db\/db mice","volume":"2017","author":"Hou","year":"2017","journal-title":"Journal of Diabetes Research"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108314_bb0385","doi-asserted-by":"crossref","first-page":"15026","DOI":"10.3390\/ijms150915026","article-title":"The protective effect of glycyrrhizic acid on renal tubular epithelial cell injury induced by high glucose","volume":"15","author":"Hou","year":"2014","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108314_bb0390","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3390\/antiox10050733","article-title":"Combined melatonin and extracorporeal shock wave therapy enhances podocyte protection and ameliorates kidney function in a diabetic nephropathy rat model","volume":"10","author":"Hsiao","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0400","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13020-021-00485-4","article-title":"Flavonoids on diabetic nephropathy: advances and therapeutic opportunities","volume":"16","author":"Hu","year":"2021","journal-title":"Chinese Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0405","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/fcp.12231","article-title":"Geniposide reduces development of streptozotocin-induced diabetic nephropathy via regulating nuclear factor-kappa B signaling pathways","volume":"31","author":"Hu","year":"2017","journal-title":"Fundamental & Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0410","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2147\/DDDT.S360346","article-title":"Astragaloside IV alleviates renal tubular epithelial-mesenchymal transition via CX3CL1-RAF\/MEK\/ERK signaling pathway in diabetic kidney disease","volume":"16","author":"Hu","year":"2022","journal-title":"Drug Design, Development and Therapy"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108314_bb0415","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/jsfa.7874","article-title":"Protective effects of allicin on streptozotocin-induced diabetic nephropathy in rats","volume":"97","author":"Huang","year":"2017","journal-title":"Journal of the Science of Food and Agriculture"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0420","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3892\/etm.2016.3913","article-title":"Allicin inhibits tubular epithelial-myofibroblast transdifferentiation under high glucose conditions in vitro","volume":"13","author":"Huang","year":"2017","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108314_bb0425","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3892\/etm.2021.11091","article-title":"Gastrodin inhibits high glucose-induced inflammation, oxidative stress and apoptosis in podocytes by activating the AMPK\/Nrf2 signaling pathway","volume":"23","author":"Huang","year":"2022","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108314_bb0430","first-page":"1796","article-title":"Expression of LncRNA KCNQ1Ot1 in diabetic nephropathy and its correlation with MEK\/ERK signaling pathway","volume":"14","author":"Huang","year":"2022","journal-title":"American Journal of Translational Research"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrfmmm.2020.111690","article-title":"Targeting AKT\/PKB to improve treatment outcomes for solid tumors","volume":"819-820","author":"Iida","year":"2020","journal-title":"Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0440","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.biopha.2017.03.102","article-title":"The effect of hesperidin and quercetin on oxidative stress, NF-\u03baB and SIRT1 levels in a STZ-induced experimental diabetes model","volume":"90","author":"Iskender","year":"2017","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108314_bb0445","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1681\/ASN.2013070810","article-title":"Genetic Targeting or pharmacologic inhibition of NADPH oxidase Nox4 provides renoprotection in long-term diabetic nephropathy","volume":"25","author":"Jha","year":"2014","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108314_bb0450","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00125-015-3796-0","article-title":"Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy","volume":"59","author":"Jha","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0455","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.mce.2016.06.029","article-title":"Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt\/NF-kappaB pathway","volume":"437","author":"Ji","year":"2016","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0460","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3892\/mmr.2016.5313","article-title":"Melatonin protects podocytes from angiotensin II-induced injury in an in vitro diabetic nephropathy model","volume":"14","author":"Ji","year":"2016","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0465","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2147\/DMSO.S195456","article-title":"Quercetin improves lipid metabolism via SCAP-SREBP2-LDLr signaling pathway in early stage diabetic nephropathy","volume":"12","author":"Jiang","year":"2019","journal-title":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108314_bb0470","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1055\/a-0636-3883","article-title":"Fangchinoline protects against renal injury in diabetic nephropathy by modulating the MAPK signaling pathway","volume":"128","author":"Jiang","year":"2020","journal-title":"Experimental and Clinical Endocrinology & Diabetes"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108314_bb0475","first-page":"5163","article-title":"Renoprotective effects of emodin against diabetic nephropathy in rat models are mediated via PI3K\/Akt\/GSK-3\u03b2 and Bax\/caspase-3 signaling pathways","volume":"14","author":"Jing","year":"2017","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0480","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.biopha.2018.10.041","article-title":"Protective effects of Astragaloside IV on endoplasmic reticulum stress-induced renal tubular epithelial cells apoptosis in type 2 diabetic nephropathy rats","volume":"109","author":"Ju","year":"2019","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0485","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/cdd.2017.186","article-title":"BCL-2 family proteins: changing partners in the dance towards death","volume":"25","author":"Kale","year":"2018","journal-title":"Cell Death and Differentiation"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108314_bb0490","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.taap.2014.05.014","article-title":"Protective effect of bioflavonoid myricetin enhances carbohydrate metabolic enzymes and insulin signaling molecules in streptozotocin-cadmium induced diabetic nephrotoxic rats","volume":"279","author":"Kandasamy","year":"2014","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0495","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejphar.2014.09.014","article-title":"Renoprotective effect of myricetin restrains dyslipidemia and renal mesangial cell proliferation by the suppression of sterol regulatory element binding proteins in an experimental model of diabetic nephropathy","volume":"743","author":"Kandasamy","year":"2014","journal-title":"European Journal of Pharmacology"},{"issue":"22","key":"10.1016\/j.pharmthera.2022.108314_bb0500","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.3390\/ijms21228577","article-title":"Tangeretin ameliorates glucose-induced podocyte injury through blocking epithelial to mesenchymal transition caused by oxidative stress and hypoxia","volume":"21","author":"Kang","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0505","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.biopha.2016.09.088","article-title":"Morin inhibits cell proliferation and fibronectin accumulation in rat glomerular mesangial cells cultured under high glucose condition","volume":"84","author":"Ke","year":"2016","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"22","key":"10.1016\/j.pharmthera.2022.108314_bb0515","doi-asserted-by":"crossref","first-page":"1900489","DOI":"10.1002\/mnfr.201900489","article-title":"Eucalyptol ameliorates dysfunction of actin cytoskeleton formation and focal adhesion assembly in glucose-loaded podocytes and diabetic kidney","volume":"63","author":"Kim","year":"2019","journal-title":"Molecular Nutrition & Food Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108314_bb0520","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00204-015-1472-2","article-title":"Compromised MAPK signaling in human diseases: An update","volume":"89","author":"Kim","year":"2015","journal-title":"Archives of Toxicology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108314_bb0525","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022293","article-title":"TGF-\u03b21 signaling and tissue fibrosis","volume":"10","author":"Kim","year":"2018","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0530","first-page":"1","article-title":"Protective effect of short-term genistein supplementation on the early stage in diabetes-induced renal damage","volume":"2013","author":"Kim","year":"2013","journal-title":"Mediators of Inflammation"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0540","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI73939","article-title":"mTOR: a pharmacologic target for autophagy regulation","volume":"125","author":"Kim","year":"2015","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0545","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1476-5381.2010.01031.x","article-title":"Effects of systemic inhibition of Rho kinase on blood pressure and renal haemodynamics in diabetic rats","volume":"162","author":"Komers","year":"2011","journal-title":"British Journal of Pharmacology"},{"issue":"13","key":"10.1016\/j.pharmthera.2022.108314_bb0550","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1517\/14656566.2013.815725","article-title":"Screening of antidiabetic and antihyperlipidemic potential of oil fromPiper longum and piperine with their possible mechanism","volume":"14","author":"Kumar","year":"2013","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0555","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s40200-021-00782-7","article-title":"Nephroprotective effect of Vanillic acid in STZ-induced diabetic rats","volume":"20","author":"Kumari","year":"2021","journal-title":"Journal of Diabetes & Metabolic Disorders"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0560","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/0886022X.2011.623564","article-title":"Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-beta1 and connective tissue growth factor in streptozotocin-induced diabetic rats","volume":"34","author":"Lai","year":"2012","journal-title":"Renal Failure"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108423","article-title":"TNF-alpha pathway and T-cell immunity are activated early during the development of diabetic nephropathy in Type II Diabetes Mellitus","volume":"215","author":"Lampropoulou","year":"2020","journal-title":"Clinical Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108314_bb0570","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/ndt\/gfv377","article-title":"Oleanolic acid andN-acetylcysteine ameliorate diabetic nephropathy through reduction of oxidative stress and endoplasmic reticulum stress in a type 2 diabetic rat model","volume":"31","author":"Lee","year":"2016","journal-title":"Nephrology, Dialysis, Transplantation"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108314_bb0575","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.bbadis.2019.02.001","article-title":"Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4\/NF-kappaB signaling and NADPH oxidase","volume":"1865","author":"Lee","year":"2019","journal-title":"Biochimica et Biophysica Acta - Molecular Basis of Disease"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104320","article-title":"Quercetin inhibited mesangial cell proliferation of early diabetic nephropathy through the Hippo pathway","volume":"146","author":"Lei","year":"2019","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0585","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lfs.2018.05.037","article-title":"Astragaloside suppresses apoptosis of the podocytes in rats with diabetic nephropathy via miR-378\/TRAF5 signaling pathway","volume":"206","author":"Lei","year":"2018","journal-title":"Life Sciences"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2022.108314_bb0590","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","article-title":"Biological functions of autophagy genes: A disease perspective","volume":"176","author":"Levine","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0595","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/216512","article-title":"Prevention of diabetic complications by activation of Nrf2: Diabetic cardiomyopathy and nephropathy","volume":"2012","author":"Li","year":"2012","journal-title":"Experimental Diabetes Research"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173449","article-title":"Geniposide alleviates diabetic nephropathy of mice through AMPK\/SIRT1\/NF-kappaB pathway","volume":"886","author":"Li","year":"2020","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106556","article-title":"\u03b2-Caryophyllene inhibits high glucose-induced oxidative stress, inflammation and extracellular matrix accumulation in mesangial cells","volume":"84","author":"Li","year":"2020","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0610","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.intimp.2017.11.040","article-title":"Oridonin protects against the inflammatory response in diabetic nephropathy by inhibiting the TLR4\/p38-MAPK and TLR4\/NF-\u03baB signaling pathways","volume":"55","author":"Li","year":"2018","journal-title":"International Immunopharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108314_bb0615","first-page":"4675","article-title":"Ursolic acid alleviates inflammation and against diabetesinduced nephropathy through TLR4mediated inflammatory pathway","volume":"18","author":"Li","year":"2018","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0620","doi-asserted-by":"crossref","first-page":"9115","DOI":"10.2147\/IJN.S256494","article-title":"Apigenin-loaded solid lipid nanoparticle attenuates diabetic nephropathy induced by streptozotocin nicotinamide Through Nrf2\/HO-1\/NF-kB signalling pathway","volume":"15","author":"Li","year":"2020","journal-title":"International Journal of Nanomedicine"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0625","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.freeradbiomed.2020.10.323","article-title":"Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy","volume":"162","author":"Li","year":"2021","journal-title":"Free Radical Biology and Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108314_bb0630","doi-asserted-by":"crossref","first-page":"9393","DOI":"10.3892\/mmr.2017.7837","article-title":"Nephrin loss is reduced by grape seed proanthocyanidins in the experimental diabetic nephropathy rat model","volume":"16","author":"Li","year":"2017","journal-title":"Molecular Medicine Reports"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108314_bb0635","first-page":"1754","article-title":"Betaine alleviates high glucoseinduced mesangial cell proliferation by inhibiting cell proliferation and extracellular matrix deposition via the AKT\/ERK1\/2\/p38 MAPK pathway","volume":"20","author":"Li","year":"2019","journal-title":"Molecular Medicine Reports"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108314_bb0640","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5582\/bst.2018.01009","article-title":"Renal protective effect of Paeoniflorin by inhibition of JAK2\/STAT3 signaling pathway in diabetic mice","volume":"12","author":"Li","year":"2018","journal-title":"Bioscience Trends"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108314_bb0645","doi-asserted-by":"crossref","first-page":"12224","DOI":"10.1080\/21655979.2022.2074619","article-title":"Tanshinone IIA down-regulates -transforming growth factor beta 1 to relieve renal tubular epithelial cell inflammation and pyroptosis caused by high glucose","volume":"13","author":"Li","year":"2022","journal-title":"Bioengineered"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108314_bb0650","first-page":"1331","article-title":"Trigonelline reduced diabetic nephropathy and insulin resistance in type 2 diabetic rats through peroxisome proliferator-activated receptor-gamma","volume":"18","author":"Li","year":"2019","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108314_bb0655","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3892\/mmr.2017.6707","article-title":"Protective effect of berberine on renal fibrosis caused by diabetic nephropathy","volume":"16","author":"Li","year":"2017","journal-title":"Molecular Medicine Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0660","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40360-020-00434-1","article-title":"Psoralen alleviates high glucose-induced HK-2 cell injury by inhibition of Smad 2 signaling via upregulation of microRNA 874","volume":"21","author":"Lin","year":"2020","journal-title":"BMC Pharmacology and Toxicology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108314_bb0665","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1159\/000493380","article-title":"Melatonin attenuates endothelial-to-mesenchymal transition of glomerular endothelial cells via regulating miR-497\/ROCK in diabetic nephropathy","volume":"43","author":"Liu","year":"2018","journal-title":"Kidney and Blood Pressure Research"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0670","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2147\/DMSO.S299375","article-title":"Emodin ameliorates renal damage and podocyte injury in a rat model of diabetic nephropathy via regulating AMPK\/mTOR-mediated autophagy signaling pathway","volume":"14","author":"Liu","year":"2021","journal-title":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0675","article-title":"Relevance of the pyroptosis-related inflammasome pathway in the pathogenesis of diabetic kidney disease","volume":"12","author":"Liu","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153650","article-title":"Effects of andrographolide on renal tubulointersticial injury and fibrosis. Evidence of its mechanism of action","volume":"91","author":"Liu","year":"2021","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0685","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41401-021-00721-5","article-title":"Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease","volume":"43","author":"Liu","year":"2022","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0690","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcdb.2019.12.010","article-title":"TGF-\u03b21 \u2013 A truly transforming growth factor in fibrosis and immunity","volume":"101","author":"Lodyga","year":"2020","journal-title":"Seminars in Cell & Developmental Biology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108314_bb0695","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s11011-021-00709-4","article-title":"RhoA\/ROCK signaling pathway and astrocytes in ischemic stroke","volume":"36","author":"Lu","year":"2021","journal-title":"Metabolic Brain Disease"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113553","article-title":"Kaempferol attenuates streptozotocin-induced diabetic nephropathy by downregulating TRAF6 expression: The role of TRAF6 in diabetic nephropathy","volume":"268","author":"Luo","year":"2021","journal-title":"Journal of Ethnopharmacology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0705","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.2147\/DMSO.S222323","article-title":"Ursolic acid treatment alleviates diabetic kidney injury by regulating the ARAP1\/AT1R signaling pathway","volume":"12","author":"Ma","year":"2019","journal-title":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0710","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.biopha.2017.12.032","article-title":"Protocatechuic acid ameliorates high glucose-induced extracellular matrix accumulation in diabetic nephropathy","volume":"98","author":"Ma","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0715","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40200-022-01014-2","article-title":"1,8 cineole protects type 2 diabetic rats against diabetic nephropathy via inducing the activity of glyoxalase-I and lowering the level of transforming growth factor-1beta","volume":"21","author":"Mahdavifard","year":"2022","journal-title":"Journal of Diabetes and Metabolic Disorders"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108314_bb0720","doi-asserted-by":"crossref","first-page":"F414","DOI":"10.1152\/ajprenal.00393.2016","article-title":"Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-\u03baB-TNF-\u03b1 and TGF-\u03b21-MAPK-fibronectin pathways","volume":"313","author":"Malik","year":"2017","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0725","first-page":"50","article-title":"Diabetic nephropathy: is there a role for oxidative stress?","volume":"116","author":"Manpreet","year":"2017","journal-title":"Free Radical Biology and Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108314_bb0730","doi-asserted-by":"crossref","first-page":"F762","DOI":"10.1152\/ajprenal.00181.2005","article-title":"Role of the JAK\/STAT signaling pathway in diabetic nephropathy","volume":"290","author":"Marrero","year":"2006","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108314_bb0735","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/13813455.2017.1419267","article-title":"Effect of phosphodiesterase inhibitors on renal functions and oxidant\/antioxidant parameters in streptozocin-induced diabetic rats","volume":"124","author":"Mehanna","year":"2018","journal-title":"Archives of Physiology and Biochemistry"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0740","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.biopha.2018.05.067","article-title":"Nano strategies for berberine delivery, a natural alkaloid of Berberis","volume":"104","author":"Mirhadi","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0745","first-page":"1","article-title":"Diabetic nephropathy induced by methylglyoxal: Gallic acid regulates kidney microRNAs and glyoxalase1-Nrf2 in male mice","author":"Mojadami","year":"2021","journal-title":"Archives of Physiology and Biochemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108314_bb0750","doi-asserted-by":"crossref","first-page":"113","DOI":"10.7555\/JBR.31.20160028","article-title":"Melatonin and\/or rowatinex attenuate streptozotocin-induced diabetic renal injury in rats","volume":"33","author":"Motawi","year":"2019","journal-title":"Journal of Biomedical Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0755","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1681\/ASN.2014010012","article-title":"Effect of pentoxifylline on renal function and urinary albumin excretion in patients with diabetic kidney disease: the PREDIAN trial","volume":"26","author":"Navarro-Gonzalez","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108314_bb0760","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jdiacomp.2010.09.003","article-title":"Pentoxifylline for renoprotection in diabetic nephropathy: the PREDIAN study. Rationale and basal results","volume":"25","author":"Navarro-Gonz\u00e1lez","year":"2011","journal-title":"Journal of Diabetes and its Complications"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0765","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"Journal of Natural Products"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0770","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/7277966","article-title":"Endoplasmic reticulum stress in diabetic nephrology: Regulation, pathological role, and therapeutic potential","volume":"2021","author":"Ni","year":"2021","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0775","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ejphar.2015.07.040","article-title":"Renoprotective effects of berberine through regulation of the MMPs\/TIMPs system in streptozocin-induced diabetic nephropathy in rats","volume":"764","author":"Ni","year":"2015","journal-title":"European Journal of Pharmacology"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108314_bb0780","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/jcmm.12837","article-title":"Renoprotective effect of berberinevia regulating thePGE2-EP1-Gaq-Ca2+signalling pathway in glomerular mesangial cells of diabetic rats","volume":"20","author":"Ni","year":"2016","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108314_bb0785","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/jdi.13119","article-title":"Berberine ameliorates renal impairment and inhibits podocyte dysfunction by targeting the phosphatidylinositol 3-kinase-protein kinase B pathway in diabetic rats","volume":"11","author":"Ni","year":"2020","journal-title":"Journal of Diabetes Investigation"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0790","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/9050828","article-title":"Melatonin attenuates contrast-induced nephropathy in diabetic rats: The role of interleukin-33 and oxidative stress","volume":"2016","author":"Onk","year":"2016","journal-title":"Mediators of Inflammation"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108314_bb0795","doi-asserted-by":"crossref","first-page":"F209","DOI":"10.1152\/ajprenal.00252.2014","article-title":"Theobromine increases NAD+\/Sirt-1 activity and protects the kidney under diabetic conditions","volume":"308","author":"Papadimitriou","year":"2015","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0800","first-page":"1","article-title":"Swertiamarin mitigates nephropathy in high-fat diet\/streptozotocin-induced diabetic rats by inhibiting the formation of advanced glycation end products","author":"Parwani","year":"2021","journal-title":"Archives of Physiology and Biochemistry"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108314_bb0805","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.3390\/molecules26092748","article-title":"Protective effects of swertiamarin against methylglyoxal-induced epithelial-mesenchymal transition by improving oxidative stress in rat kidney epithelial (NRK-52E) cells","volume":"26","author":"Parwani","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0810","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/5584_2020_527","article-title":"Animal models and renal biomarkers of diabetic nephropathy","volume":"1307","author":"Perez-Lopez","year":"2021","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108314_bb0815","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1016","article-title":"Recent novel approaches to limit oxidative stress and inflammation in diabetic complications","volume":"7","author":"Pickering","year":"2018","journal-title":"Clinical & Translational Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108314_bb0820","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00018-014-1762-5","article-title":"Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling","volume":"72","author":"P\u0142\u00f3ciennikowska","year":"2015","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108314_bb0825","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1039\/C9FO02398D","article-title":"Protective effect of ferulic acid on STZ-induced diabetic nephropathy in rats","volume":"11","author":"Qi","year":"2020","journal-title":"Food & Function"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0830","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.freeradbiomed.2019.09.003","article-title":"Bergenin impedes the generation of extracellular matrix in glomerular mesangial cells and ameliorates diabetic nephropathy in mice by inhibiting oxidative stress via the mTOR\/\u03b2-TrcP\/Nrf2 pathway","volume":"145","author":"Qiao","year":"2019","journal-title":"Free Radical Biology and Medicine"},{"issue":"16","key":"10.1016\/j.pharmthera.2022.108314_bb0835","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1111\/bph.14935","article-title":"Berberine protects against diabetic kidney disease via promoting PGC-1\u03b1-regulated mitochondrial energy homeostasis","volume":"177","author":"Qin","year":"2020","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0840","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.mce.2017.01.009","article-title":"Berberine exerts renoprotective effects by regulating the AGEs-RAGE signaling pathway in mesangial cells during diabetic nephropathy","volume":"443","author":"Qiu","year":"2017","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108314_bb0845","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.amjms.2017.12.015","volume":"355","author":"Rabizadeh","year":"2017","journal-title":"The American Journal of the Medical Sciences"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108314_bb0850","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jcjd.2015.08.016","article-title":"The role of renin angiotensin aldosterone system genes in diabetic nephropathy","volume":"40","author":"Rahimi","year":"2016","journal-title":"Canadian Journal of Diabetes"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0855","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172763","article-title":"Tetramethylpyrazine alleviates diabetic nephropathy through the activation of Akt signalling pathway in rats","volume":"865","author":"Rai","year":"2019","journal-title":"European Journal of Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108314_bb0860","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1139\/bcb-2017-0230","article-title":"Mesenchymal stem cells pretreated with melatonin ameliorate kidney functions in a rat model of diabetic nephropathy","volume":"96","author":"Rashed","year":"2018","journal-title":"Biochemistry and Cell Biology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0865","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.semcancer.2019.06.002","article-title":"Akt in cancer: Mediator and more","volume":"59","author":"Revathidevi","year":"2019","journal-title":"Seminars in Cancer Biology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0870","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cyto.2018.10.022","article-title":"Interleukins as modulators of angiogenesis and anti-angiogenesis in tumors","volume":"118","author":"Ribatti","year":"2019","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108314_bb0875","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3109\/08860221003602645","article-title":"Captopril and combination therapy of captopril and pentoxifylline in reducing proteinuria in diabetic nephropathy","volume":"32","author":"Roozbeh","year":"2010","journal-title":"Renal Failure"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108314_bb0880","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3109\/13880209.2015.1110599","article-title":"Naringenin ameliorates streptozotocin-induced diabetic rat renal impairment by downregulation of TGF-beta1 and IL-1 via modulation of oxidative stress correlates with decreased apoptotic events","volume":"54","author":"Roy","year":"2016","journal-title":"Pharmaceutical Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108314_bb0885","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s12291-018-0743-0","article-title":"Caffeic acid modulates miR-636 expression in diabetic nephropathy rats","volume":"34","author":"Salem","year":"2019","journal-title":"Indian Journal of Clinical Biochemistry"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0890","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.lfs.2016.06.002","article-title":"Cepharanthine and Piperine ameliorate diabetic nephropathy in rats: role of NF-kappaB and NLRP3 inflammasome","volume":"157","author":"Samra","year":"2016","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0895","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/1497449","article-title":"Diabetic nephropathy: Challenges in pathogenesis, diagnosis, and treatment","volume":"2021","author":"Samsu","year":"2021","journal-title":"BioMed Research International"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0900","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejphar.2018.06.001","article-title":"AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions","volume":"833","author":"Sanajou","year":"2018","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2015.11.033","article-title":"Protective effect of thymol on high fat diet induced diabetic nephropathy in C57BL\/6J mice","volume":"245","author":"Saravanan","year":"2016","journal-title":"Chemico-Biological Interactions"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0910","first-page":"22","article-title":"Metabolic and anti-inflammatory response to melatonin administration in patients with diabetic nephropathy","volume":"1","author":"Satari","year":"2021","journal-title":"Iranian Journal of Kidney Diseases"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb0915","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/ATVBAHA.117.310221","article-title":"Highlighting diabetes mellitus","volume":"38","author":"Schmidt","year":"2018","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108314_bb0920","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41581-020-00343-w","article-title":"WNT-beta-catenin signalling - a versatile player in kidney injury and repair","volume":"17","author":"Schunk","year":"2021","journal-title":"Nature Reviews. Nephrology"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108314_bb0925","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1681\/ASN.2015060676","article-title":"Caspase-1, but not caspase-3, promotes diabetic nephropathy","volume":"27","author":"Shahzad","year":"2016","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108314_bb0930","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/cdd.2014.216","article-title":"Old, new and emerging functions of caspases","volume":"22","author":"Shalini","year":"2015","journal-title":"Cell Death and Differentiation"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0935","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fphar.2015.00262","article-title":"NLRP3 inflammasome and its inhibitors: a review","volume":"6","author":"Shao","year":"2015","journal-title":"Frontiers in Pharmacology"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108314_bb0940","first-page":"492","article-title":"Expression analysis of microRNAs and their target genes during experimental diabetic renal lesions in rats administered with ginsenoside Rb1 and trigonelline","volume":"74","author":"Shao","year":"2019","journal-title":"Pharmazie"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0945","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3389\/fphar.2019.00566","article-title":"Paeoniflorin ameliorates macrophage infiltration and activation by inhibiting the TLR4 signaling pathway in diabetic nephropathy","volume":"10","author":"Shao","year":"2019","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0950","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.2147\/DDDT.S149504","article-title":"Paeoniflorin attenuates incipient diabetic nephropathy in streptozotocin-induced mice by the suppression of the Toll-like receptor-2 signaling pathway","volume":"11","author":"Shao","year":"2017","journal-title":"Drug Design, Development and Terapy"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0955","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.biopha.2018.10.195","article-title":"Kaempferol attenuates diabetic nephropathy by inhibiting RhoA\/Rho-kinase mediated inflammatory signalling","volume":"109","author":"Sharma","year":"2019","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0960","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153235","article-title":"Kaempferol in ameliorating diabetes-induced fibrosis and renal damage: An in vitro and in vivo study in diabetic nephropathy mice model","volume":"76","author":"Sharma","year":"2020","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108314_bb0965","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13158","article-title":"Salidroside ameliorates diabetic nephropathy in rats by activating renal AMPK\/SIRT1 signaling pathway","volume":"44","author":"Shati","year":"2020","journal-title":"Journal of Food Biochemistry"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0970","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/1903627","article-title":"Ginsenoside Rg1 alleviates podocyte EMT passage by regulating AKT\/GSK3\u03b2\/\u03b2-catenin pathway by restoring autophagic activity","volume":"2020","author":"Shi","year":"2020","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0975","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109625","article-title":"Catalpol ameliorates endothelial dysfunction and inflammation in diabetic nephropathy via suppression of RAGE\/RhoA\/ROCK signaling pathway","volume":"348","author":"Shu","year":"2021","journal-title":"Chemico-Biological Interactions"},{"key":"10.1016\/j.pharmthera.2022.108314_bb0980","doi-asserted-by":"crossref","DOI":"10.12659\/MSMBR.928265","article-title":"Paclitaxel ameliorates palmitate-induced injury in mouse podocytes","volume":"26","author":"Son","year":"2020","journal-title":"Medical Science Monitor Basic Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108314_bb0985","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1177\/0300060518778711","article-title":"Astragaloside IV ameliorates early diabetic nephropathy by inhibition of MEK1\/2-ERK1\/2-RSK2 signaling in streptozotocin-induced diabetic mice","volume":"46","author":"Song","year":"2018","journal-title":"Journal of International Medical Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108314_bb0990","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/0886022X.2016.1149688","article-title":"Ameliorative effects of pentoxifylline on NOS induced by diabetes in rat kidney","volume":"38","author":"Sonmez","year":"2016","journal-title":"Renal Failure"},{"issue":"16","key":"10.1016\/j.pharmthera.2022.108314_bb0995","doi-asserted-by":"crossref","first-page":"990","DOI":"10.21037\/atm-20-5548","article-title":"Tetrandrine mediates renal function and redox homeostasis in a streptozotocin-induced diabetic nephropathy rat model through Nrf2\/HO-1 reactivation","volume":"8","author":"Su","year":"2020","journal-title":"Annals of Translational Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108314_bb1000","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3904\/kjim.2012.27.2.163","article-title":"Phosphodiesterase inhibitor improves renal tubulointerstitial hypoxia of the diabetic rat kidney","volume":"27","author":"Sun","year":"2012","journal-title":"The Korean Journal of Internal Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108314_bb1005","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/path.2961","article-title":"Low-dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating miR-192","volume":"225","author":"Sun","year":"2011","journal-title":"The Journal of Pathology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108314_bb1010","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/1440-1681.12402","article-title":"Renoprotective effect of berberine on type 2 diabetic nephropathy in rats","volume":"42","author":"Sun","year":"2015","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cbi.2018.07.011","article-title":"Artesunate ameliorates high glucose-induced rat glomerular mesangial cell injury by suppressing the TLR4\/NF-\u03baB\/NLRP3 inflammasome pathway","volume":"293","author":"Sun","year":"2018","journal-title":"Chemico-Biological Interactions"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/590541","article-title":"Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS Knockout Mice","volume":"2014","author":"Takahashi","year":"2014","journal-title":"Journal of Diabetes Research"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1025","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.2147\/DDDT.S143805","article-title":"Effect of echinacoside on kidney fibrosis by inhibition of TGF-β1\/Smads signaling pathway in the db\/db mice model of diabetic nephropathy","volume":"11","author":"Tang","year":"2017","journal-title":"Drug Design, Development and Terapy"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb1030","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1038\/s41598-020-59411-7","article-title":"Quercetin liposomes ameliorate streptozotocin-induced diabetic nephropathy in diabetic rats","volume":"10","author":"Tang","year":"2020","journal-title":"Scientific Reports"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108314_bb1035","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1007\/s11033-014-3196-4","article-title":"Berberine regulates the expression of E-prostanoid receptors in diabetic rats with nephropathy","volume":"41","author":"Tang","year":"2014","journal-title":"Molecular Biology Reports"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108314_bb1040","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/1753-0407.12349","article-title":"Renoprotective effects of berberine and its potential effect on the expression of beta-arrestins and intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in streptozocin-diabetic nephropathy rats","volume":"8","author":"Tang","year":"2016","journal-title":"Journal of Diabetes"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108314_bb1045","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s40620-014-0136-2","article-title":"Nitric oxide in the normal kidney and in patients with diabetic nephropathy","volume":"28","author":"Tessari","year":"2015","journal-title":"Journal of Nephrology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108314_bb1050","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000477820","article-title":"Role of glycyrrhizin in the reduction of inflammation in diabetic kidney disease","volume":"137","author":"Thakur","year":"2017","journal-title":"Nephron"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1055","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.2147\/DDDT.S167405","article-title":"Emodin mitigates podocytes apoptosis induced by endoplasmic reticulum stress through the inhibition of the PERK pathway in diabetic nephropathy","volume":"12","author":"Tian","year":"2018","journal-title":"Drug Design, Development and Terapy"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1060","doi-asserted-by":"crossref","first-page":"7799","DOI":"10.2147\/IJN.S146978","article-title":"Quercetin nanoparticle complex attenuated diabetic nephropathy via regulating the expression level of ICAM-1 on endothelium","volume":"12","author":"Tong","year":"2017","journal-title":"International Journal of Nanomedicine"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173387","article-title":"Resveratrol ameliorates renal damage by inhibiting oxidative stress-mediated apoptosis of podocytes in diabetic nephropathy","volume":"885","author":"Wang","year":"2020","journal-title":"European Journal of Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108314_bb1070","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1007\/s11033-012-2321-5","article-title":"Renoprotective effects of berberine and its possible molecular mechanisms in combination of high-fat diet and low-dose streptozotocin-induced diabetic rats","volume":"40","author":"Wang","year":"2013","journal-title":"Molecular Biology Reports"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/323171","article-title":"Protective effects of luteolin on diabetic nephropathy in STZ-induced diabetic rats","volume":"2011","author":"Wang","year":"2011","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108314_bb1080","doi-asserted-by":"crossref","first-page":"6197","DOI":"10.1007\/s12035-019-1524-3","article-title":"The ERK pathway: Molecular mechanisms and treatment of depression","volume":"56","author":"Wang","year":"2019","journal-title":"Molecular Neurobiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108314_bb1085","first-page":"2870","article-title":"Lycopene attenuates high glucose-mediated apoptosis in MPC5 podocytes by promoting autophagy via the PI3K\/AKT signaling pathway","volume":"20","author":"Wang","year":"2020","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1090","first-page":"1","article-title":"Ginsenoside Rg1 alleviates podocyte injury induced by hyperlipidemia via targeting the mTOR\/NF-\u03baB\/NLRP3 axis","volume":"2020","author":"Wang","year":"2020","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108314_bb1095","first-page":"2488","article-title":"Effects of melatonin on diabetic nephropathy rats via Wnt\/beta-catenin signaling pathway and TGF-beta-Smad signaling pathway","volume":"11","author":"Wang","year":"2018","journal-title":"International Journal of Clinical and Experimental Pathology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1100","first-page":"2431","article-title":"Astragaloside IV improves renal function and fibrosis via inhibition of miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic mice","volume":"12","author":"Wang","year":"2018"},{"issue":"14","key":"10.1016\/j.pharmthera.2022.108314_bb1105","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1055\/s-0042-110859","article-title":"Rutin prevents high glucose-induced renal glomerular endothelial hyperpermeability by inhibiting the ROS\/Rhoa\/ROCK signaling pathway","volume":"82","author":"Wang","year":"2016","journal-title":"Planta Medica"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb1110","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1080\/21655979.2021.2012919","article-title":"miR-188-3p abolishes germacrone-mediated podocyte protection in a mouse model of diabetic nephropathy in type I diabetes through triggering mitochondrial injury","volume":"13","author":"Wang","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1115","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.12659\/MSM.910868","article-title":"Genistein and Myd88 activate autophagy in high glucose-induced renal podocytes in vitro","volume":"24","author":"Wang","year":"2018","journal-title":"Medical Science Monitor"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1120","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/1753-0407.13174","article-title":"Low-dose colchicine in type 2 diabetes with microalbuminuria: A double-blind randomized clinical trial","volume":"13","author":"Wang","year":"2021","journal-title":"Journal of Diabetes"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108314_bb1125","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190987","article-title":"Astragaloside IV attenuates high glucose-induced EMT by inhibiting the TGF-\u03b2\/Smad pathway in renal proximal tubular epithelial cells","volume":"40","author":"Wang","year":"2020","journal-title":"Bioscience Reports"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1130","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.intimp.2019.04.040","article-title":"Protective effects of pyrroloquinoline quinone against oxidative stress-induced cellular senescence and inflammation in human renal tubular epithelial cells via Keap1\/Nrf2 signaling pathway","volume":"72","author":"Wang","year":"2019","journal-title":"International Immunopharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108314_bb1135","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.bbrc.2018.11.140","article-title":"Pyrroloquinoline quinine protects HK-2 cells against high glucose-induced oxidative stress and apoptosis through Sirt3 and PI3K\/Akt\/FoxO3a signaling pathway","volume":"508","author":"Wang","year":"2019","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108314_bb1140","first-page":"1584","article-title":"Melatonin ameliorates hyperglycaemia-induced renal inflammation by inhibiting the activation of TLR4 and TGF-beta1\/Smad3 signalling pathway","volume":"12","author":"Wei","year":"2020","journal-title":"American Journal of Translational Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb1145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/jpi.12296","article-title":"Melatonin nephroprotective action in Zucker diabetic fatty rats involves its inhibitory effect on NADPH oxidase","volume":"60","author":"Winiarska","year":"2016","journal-title":"Journal of Pineal Research"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1150","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154748","article-title":"Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy","volume":"118","author":"Wu","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1155","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.metabol.2018.01.002","article-title":"IL-6 receptor blockade ameliorates diabetic nephropathy via inhibiting inflammasome in mice","volume":"83","author":"Wu","year":"2018","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb1160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/10799893.2020.1784939","article-title":"Plantamajoside inhibits high glucose-induced oxidative stress, inflammation, and extracellular matrix accumulation in rat glomerular mesangial cells through the inactivation of Akt\/NF-\u03baB pathway","volume":"41","author":"Xiao","year":"2021","journal-title":"Journal of Receptors and Signal Transduction"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1165","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104559","article-title":"Gentiopicroside activates the bile acid receptor Gpbar1 (TGR5) to repress NF-kappaB pathway and ameliorate diabetic nephropathy","volume":"151","author":"Xiao","year":"2020","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1170","first-page":"1","article-title":"A glimpse of the pathogenetic mechanisms of Wnt\/\u03b2-catenin signaling in diabetic nephropathy","volume":"2013","author":"Xiao","year":"2013","journal-title":"BioMed Research International"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108314_bb1175","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.yexcr.2014.07.019","article-title":"RhoA\/rho kinase signaling reduces connexin43 expression in high glucose-treated glomerular mesangial cells with zonula occludens-1 involvement","volume":"327","author":"Xie","year":"2014","journal-title":"Experimental Cell Research"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2022.108314_bb1180","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.mce.2013.01.007","article-title":"Activation of RhoA\/ROCK regulates NF-\u03baB signaling pathway in experimental diabetic nephropathy","volume":"369","author":"Xie","year":"2013","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1185","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119068","article-title":"Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPAR\u03b3-Klotho-FoxO1 axis in diabetic nephropathy","volume":"269","author":"Xing","year":"2021","journal-title":"Life Sciences"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108314_bb1190","doi-asserted-by":"crossref","first-page":"1410560508","DOI":"10.1177\/0300060520903642","article-title":"Protective effects of luteolin on nephrotoxicity induced by long-term hyperglycaemia in rats","volume":"48","author":"Xiong","year":"2020","journal-title":"Journal of International Medical Research"},{"issue":"18","key":"10.1016\/j.pharmthera.2022.108314_bb1195","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.21037\/atm-20-5811","article-title":"Ligustilide alleviates podocyte injury via suppressing the SIRT1\/NF-\u03baB signaling pathways in rats with diabetic nephropathy","volume":"8","author":"Xu","year":"2020","journal-title":"Annals of Translational Medicine"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1200","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.biopha.2018.06.055","article-title":"Ursolic acid improves diabetic nephropathy via suppression of oxidative stress and inflammation in streptozotocin-induced rats","volume":"105","author":"Xu","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108314_bb1205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jphs.2018.11.013","article-title":"Daphnetin inhibits high glucose-induced extracellular matrix accumulation, oxidative stress and inflammation in human glomerular mesangial cells","volume":"139","author":"Xu","year":"2019","journal-title":"Journal of Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1210","first-page":"5773","article-title":"Tanshinone IIA ameliorates streptozotocin-induced diabetic nephropathy","volume":"14","author":"Xu","year":"2020","journal-title":"Partly by Attenuating PERK Pathway-Induced Fibrosis."},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108314_bb1215","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/19336918.2015.1016686","article-title":"A new role for the PI3K\/Akt signaling pathway in the epithelial-mesenchymal transition","volume":"9","author":"Xu","year":"2015","journal-title":"Cell Adhesion & Migration"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb1220","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180992","article-title":"Apoptosis and apoptotic body: disease message and therapeutic target potentials","volume":"39","author":"Xu","year":"2019","journal-title":"Bioscience Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb1225","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41419-020-03312-0","article-title":"METTL14-regulated PI3K\/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial\u2013mesenchymal transition of renal tubular cells in diabetic kidney disease","volume":"12","author":"Xu","year":"2021","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1230","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.phymed.2018.10.031","article-title":"Salidroside stimulates the Sirt1\/PGC-1alpha axis and ameliorates diabetic nephropathy in mice","volume":"54","author":"Xue","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1235","first-page":"1","article-title":"Naringenin ameliorated kidney injury through Let-7a\/TGFBR1 signaling in diabetic nephropathy","volume":"2016","author":"Yan","year":"2016","journal-title":"Journal of Diabetes Research"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1240","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2147\/DDDT.S124971","article-title":"Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch\/snail pathway in diabetic nephropathy model KKAy mice","volume":"11","author":"Yang","year":"2017","journal-title":"Drug Design, Development and Terapy"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108314_bb1245","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/08923973.2016.1142560","article-title":"Bergenin ameliorates diabetic nephropathy in rats via suppressing renal inflammation and TGF- \u03b2 1-Smads pathway","volume":"38","author":"Yang","year":"2016","journal-title":"Immunopharmacology and Immunotoxicology"},{"issue":"13","key":"10.1016\/j.pharmthera.2022.108314_bb1250","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.phymed.2011.05.003","article-title":"Protective effect of tetramethylpyrazine isolated from Ligusticum chuanxiong on nephropathy in rats with streptozotocin-induced diabetes","volume":"18","author":"Yang","year":"2011","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1255","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.freeradbiomed.2018.06.042","article-title":"Nox4 in renal diseases: An update","volume":"124","author":"Yang","year":"2018","journal-title":"Free Radical Biology & Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108314_bb1260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151857","article-title":"Amelioration of diabetic mouse nephropathy by catalpol correlates with down-regulation of Grb10 expression and activation of insulin-like growth factor 1 \/ insulin-like growth factor 1 receptor signaling","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108314_bb1265","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1002\/jcb.26806","article-title":"Crocin improves renal function by declining Nox-4, IL-18, and p53 expression levels in an experimental model of diabetic nephropathy","volume":"119","author":"Yaribeygi","year":"2018","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1270","doi-asserted-by":"crossref","first-page":"12161","DOI":"10.1002\/jcp.27950","article-title":"Protective effects of plant-derived natural products on renal complications","volume":"234","author":"Yaribeygi","year":"2019","journal-title":"Journal of Cellular Physiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108314_bb1275","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.bbrc.2016.06.152","article-title":"Sinomenine alleviates high glucose-induced renal glomerular endothelial hyperpermeability by inhibiting the activation of RhoA\/ROCK signaling pathway","volume":"477","author":"Yin","year":"2016","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb1280","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1080\/0886022X.2017.1313164","article-title":"Molecular mechanisms involved in podocyte EMT and concomitant diabetic kidney diseases: An update","volume":"39","author":"Ying","year":"2017","journal-title":"Renal Failure"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108314_bb1285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073428","article-title":"Plumbagin ameliorates diabetic nephropathy via interruption of pathways that include NOX4 signalling","volume":"8","author":"Yong","year":"2013","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.pharmthera.2022.108314_bb1290","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.3390\/ijms21197003","article-title":"Sauchinone protects renal mesangial cell dysfunction against angiotensin II by improving renal fibrosis and inflammation","volume":"21","author":"Yoon","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2019.03.073","article-title":"Luteolin attenuates high glucose-induced podocyte injury via suppressing NLRP3 inflammasome pathway","volume":"225","author":"Yu","year":"2019","journal-title":"Life Sciences"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108314_bb1300","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.3390\/ijms21072346","article-title":"Understanding MAPK signaling pathways in apoptosis","volume":"21","author":"Yue","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"08","key":"10.1016\/j.pharmthera.2022.108314_bb1305","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1142\/S0192415X17500926","article-title":"Berberine ameliorates diabetic neuropathy: TRPV1 modulation by PKC pathway","volume":"45","author":"Zan","year":"2017","journal-title":"The American Journal of Chinese Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb1310","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/s41598-018-38425-2","article-title":"MG132 protects against renal dysfunction by regulating Akt-mediated inflammation in diabetic nephropathy","volume":"9","author":"Zeng","year":"2019","journal-title":"Scientific Reports"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108314_bb1315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042115","article-title":"Oleanolic acid reduces hyperglycemia beyond treatment period with Akt\/FoxO1-induced suppression of hepatic gluconeogenesis in type-2 diabetic mice","volume":"7","author":"Zeng","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108314_bb1320","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s11095-021-03104-x","article-title":"Berberine improves the protective effects of metformin on diabetic nephropathy in db\/db Mice through Trib1-dependent Inhibiting Inflammation","volume":"38","author":"Zhang","year":"2021","journal-title":"Pharmaceutical Research"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108314_bb1325","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.3390\/ijms17091404","article-title":"Wnt\/\u03b2-catenin signaling mediated-UCH-L1 expression in podocytes of diabetic nephropathy","volume":"17","author":"Zhang","year":"2016","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1330","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117966","article-title":"Artemisinin attenuates early renal damage on diabetic nephropathy rats through suppressing TGF-beta1 regulator and activating the Nrf2 signaling pathway","volume":"256","author":"Zhang","year":"2020","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2017.04.006","article-title":"Naringin ameliorates diabetic nephropathy by inhibiting NADPH oxidase 4","volume":"804","author":"Zhang","year":"2017","journal-title":"European Journal of Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108314_bb1340","first-page":"193","article-title":"Crocin protects the renal tubular epithelial cells against high glucose-induced injury and oxidative stress via regulation of the SIRT1\/Nrf2 pathway","volume":"25","author":"Zhang","year":"2022","journal-title":"Iranian Journal of Basic Medical Sciences"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1345","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3389\/fphar.2018.00512","article-title":"Paeonol ameliorates diabetic renal fibrosis through promoting the activation of the Nrf2\/ARE pathway via up-regulating Sirt1","volume":"9","author":"Zhang","year":"2018","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1350","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119542","article-title":"Crocin alleviates the inflammation and oxidative stress responses associated with diabetic nephropathy in rats via NLRP3 inflammasomes","volume":"278","author":"Zhang","year":"2021","journal-title":"Life Sciences"},{"issue":"9818","key":"10.1016\/j.pharmthera.2022.108314_bb1355","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","article-title":"Prevalence of chronic kidney disease in China: a cross-sectional survey","volume":"379","author":"Zhang","year":"2012","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108314_bb1360","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1055\/a-0998-7985","article-title":"Luteolin attenuates diabetic nephropathy through suppressing inflammatory response and oxidative stress by inhibiting STAT3 pathway","volume":"129","author":"Zhang","year":"2021","journal-title":"Experimental and Clinical Endocrinology & Diabetes"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1365","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172955","article-title":"Highly bioavailable berberine formulation ameliorates diabetic nephropathy through the inhibition of glomerular mesangial matrix expansion and the activation of autophagy","volume":"873","author":"Zhang","year":"2020","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1370","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2147\/DMSO.S237451","article-title":"Curcumin inhibited podocyte cell apoptosis and accelerated cell autophagy in diabetic nephropathy via regulating Beclin1\/UVRAG\/Bcl2","volume":"13","author":"Zhang","year":"2020","journal-title":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108314_bb1375","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s13105-020-00747-z","article-title":"Baicalin suppresses renal fibrosis through microRNA-124\/TLR4\/NF-\u03baB axis in streptozotocin-induced diabetic nephropathy mice and high glucose-treated human proximal tubule epithelial cells","volume":"76","author":"Zhang","year":"2020","journal-title":"Journal of Physiology and Biochemistry"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108314_bb1380","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1002\/jcp.27306","article-title":"Resveratrol ameliorates podocyte damage in diabetic mice via SIRT1\/PGC-1\u03b1 mediated attenuation of mitochondrial oxidative stress","volume":"234","author":"Zhang","year":"2019","journal-title":"Journal of Cellular Physiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108314_bb1385","doi-asserted-by":"crossref","first-page":"308","DOI":"10.5582\/bst.2017.01104","article-title":"Paeoniflorin prevents TLR2\/4-mediated inflammation in type 2 diabetic nephropathy","volume":"11","author":"Zhang","year":"2017","journal-title":"Bioscience Trends"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108314_bb1390","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3390\/ijms17081327","article-title":"Protective effects of berberine on renal injury in streptozotocin (STZ)-induced diabetic mice","volume":"17","author":"Zhang","year":"2016","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1395","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.biopha.2018.06.036","article-title":"Involvement of the TGF\u03b21- ILK-Akt signaling pathway in the effects of hesperidin in type 2 diabetic nephropathy","volume":"105","author":"Zhang","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2022.108314_bb1400","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fimmu.2019.00276","article-title":"NLRP3 inflammasome and inflammatory bowel disease","volume":"10","author":"Zhen","year":"2019","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb1405","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12882-020-01833-6","article-title":"Kidney-targeted baicalin-lysozyme conjugate ameliorates renal fibrosis in rats with diabetic nephropathy induced by streptozotocin","volume":"21","author":"Zheng","year":"2020","journal-title":"BMC Nephrology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108314_bb1410","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1039\/D1FO02733F","article-title":"Dioscin relieves diabetic nephropathy via suppressing oxidative stress and apoptosis, and improving mitochondrial quality and quantity control","volume":"13","author":"Zhong","year":"2022","journal-title":"Food & Function"},{"issue":"42","key":"10.1016\/j.pharmthera.2022.108314_bb1415","doi-asserted-by":"crossref","first-page":"28827","DOI":"10.1074\/jbc.M114.596593","article-title":"Hydrogen sulfide alleviates diabetic nephropathy in a streptozotocin-induced diabetic rat model","volume":"289","author":"Zhou","year":"2014","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108314_bb1420","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40659-018-0157-8","article-title":"Berberine ameliorates diabetic nephropathy by inhibiting TLR4\/NF-\u03baB pathway","volume":"51","author":"Zhu","year":"2018","journal-title":"Biological Research"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372582200208X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372582200208X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:26:38Z","timestamp":1759011998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016372582200208X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":281,"alternative-id":["S016372582200208X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108314","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A natural products solution to diabetic nephropathy therapy","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108314","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108314"}}